Scientech Research LLC Acquires New Holdings in Tempus AI, Inc. $TEM

Key Points

• Scientech Research LLC has acquired 21,694 shares of Tempus AI, Inc., valued at approximately $1,047,000, during the first quarter.
• CEO Eric P. Lefkofsky sold 332,500 shares for a total of $24.6 million, representing a 3.49% decrease in his ownership.
• Tempus AI reported a revenue increase of 89.5% year-over-year, with a total revenue of $314.64 million for the quarter, surpassing analysts' expectations.

Scientech Research LLC purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 21,694 shares of the company's stock, valued at approximately $1,047,000.

A number of other large investors have also recently bought and sold shares of the business. Cherry Tree Wealth Management LLC acquired a new stake in shares of Tempus AI in the first quarter worth $31,000. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Tempus AI in the first quarter worth $33,000. Continuum Advisory LLC acquired a new position in shares of Tempus AI in the first quarter valued at $39,000. Bartlett & CO. Wealth Management LLC lifted its stake in Tempus AI by 100.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock worth $39,000 after purchasing an additional 400 shares during the period. Finally, Nemes Rush Group LLC acquired a new stake in Tempus AI during the first quarter valued at approximately $39,000. 24.22% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Needham & Company LLC reissued a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a report on Friday, August 8th. Morgan Stanley upped their price objective on Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a report on Tuesday, August 12th. HC Wainwright began coverage on Tempus AI in a report on Tuesday, September 2nd. They issued a "buy" rating and a $90.00 price target on the stock. Bank of America raised their target price on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Finally, Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $69.50.

Tempus AI Trading Up 1.0%

TEM traded up $0.79 during mid-day trading on Tuesday, hitting $81.01. The stock had a trading volume of 6,502,834 shares, compared to its average volume of 12,318,353. The stock's fifty day simple moving average is $65.72 and its 200-day simple moving average is $59.01. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. The firm has a market capitalization of $14.07 billion, a price-to-earnings ratio of -68.08 and a beta of 5.07. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. During the same quarter in the prior year, the company earned ($6.86) earnings per share. The business's quarterly revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. As a group, research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Transactions at Tempus AI

In other news, EVP Erik Phelps sold 3,664 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $273,517.60. Following the completion of the transaction, the executive vice president directly owned 94,115 shares of the company's stock, valued at $7,025,684.75. This trade represents a 3.75% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the company's stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $74.10, for a total value of $24,638,250.00. Following the completion of the sale, the chief executive officer owned 9,207,533 shares in the company, valued at $682,278,195.30. This represents a 3.49% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,108,951 shares of company stock worth $77,660,938. 26.27% of the stock is currently owned by company insiders.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.